CAS NO: | 888958-27-8 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
生物活性 | SARS-CoV-IN-3 is an effective inhibitor ofSARS-CoVreplication. SARS-CoV-IN-3 shows anti-Coronavirus activity with anEC50of 3.6 μM in Vero cells. SARS-CoV-IN-3 inhibits the 3D7 and W2 strains ofP. falciparumwithIC50s of 11.7 and 20.4 nM; andIC90s of 29.19 and 56 nM; respectively. SARS-CoV-IN-3 reducesHIV-1-induced cytopathic effect with anEC50of 10 μM in MT-4 cells[1]. | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | SARS-CoV-IN-3 (Compound 4) inhibits in vitro growth ofPlasmodium falciparumfar better than Chloroquine (CQ)[1]. | ||||||||||||||||
分子量 | 469.74 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C25H20ClFeN3O | ||||||||||||||||
CAS 号 | 888958-27-8 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 7.81 mg/mL(16.63 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |